A single-arm exploratory clinical study of β-glucan combined with camrelizumab and SOX chemotherapy as first-line treatment for advanced gastric adenocarcinoma.

被引：0
|
作者：
Zhu, Wenyu
Chu, Yunqian
He, Xuan
Jiang, Hua
Zhu, Chan
Zhang, Xing
Wu, Fangfang
Dai, Hanjue
Xian, Qingying
Xue, Ya
机构：
[1] Nanjing Med Univ, Affiliated Changzhou Peoples Hosp 2, Dept Oncol, Changzhou, Jiangsu, Peoples R China
[2] Dalian Med Univ, Grad Sch, Dalian, Peoples R China
[3] Jiangsu Simcere Diagnost Co Ltd, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16008
引用
收藏
页数：1
相关论文
共 50 条
  • [31] TISLELIZUMAB IN COMBINATION WITH ANLOTINIB AS FIRST-LINE TREATMENT FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA: A SINGLE-CENTER, SINGLE-ARM, EXPLORATORY PHASE I I CLINICAL STUDY
    Laoguo, Shixue
    Huang, Huasheng
    Zeng, Jie
    Jiang, Yangfeng
    Liu, Cuizhen
    Mo, Ning
    Zhu, Guangzhi
    Ma, Fuchao
    Peng, Tao
    Yang, Lihua
    Zeng, Zhiming
    Ma, Jie
    HEPATOLOGY, 2023, 78 : S1904 - S1904
  • [32] Study protocol: A single-arm, multicenter, phase II trial of camrelizumab plus apatinib for advanced nonsquamous NSCLC previously treated with first-line immunotherapy
    Xing, Puyuan
    Wang, Mengzhao
    Zhao, Jun
    Zhong, Wei
    Chi, Yujia
    Xu, Ziyi
    Li, Junling
    THORACIC CANCER, 2021, 12 (20) : 2825 - 2828
  • [33] First-line combination of toripalimab and chemotherapy in advanced thymic carcinoma: A prospective, single-arm, phase II trial
    Shi, H.
    Zhu, H.
    Feng, Y.
    Liu, Y.
    Xing, P.
    Hu, X.
    ANNALS OF ONCOLOGY, 2023, 34 : S1132 - S1133
  • [34] Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, single-arm trial
    Ming Liu
    Guihuan Qiu
    Wenhui Guan
    Xiaohong Xie
    Xinqing Lin
    Zhanhong Xie
    Jiexia Zhang
    Yinyin Qin
    Haijian Du
    Xin Chen
    Yu Deng
    Shiyue Li
    Nanshan Zhong
    Chengzhi Zhou
    Signal Transduction and Targeted Therapy, 10 (1)
  • [35] Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study
    Guo-Ming Shi
    Xiao-Yong Huang
    Dong Wu
    Hui-Chuan Sun
    Fei Liang
    Yuan Ji
    Yi Chen
    Guo-Huan Yang
    Jia-Cheng Lu
    Xian-Long Meng
    Xin-Ying Wang
    Lei Sun
    Ning-Ling Ge
    Xiao-Wu Huang
    Shuang-Jian Qiu
    Xin-Rong Yang
    Qiang Gao
    Yi-Feng He
    Yang Xu
    Jian Sun
    Zheng-Gang Ren
    Jia Fan
    Jian Zhou
    Signal Transduction and Targeted Therapy, 8
  • [36] Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study
    Shi, Guo-Ming
    Huang, Xiao-Yong
    Wu, Dong
    Sun, Hui-Chuan
    Liang, Fei
    Ji, Yuan
    Chen, Yi
    Yang, Guo-Huan
    Lu, Jia-Cheng
    Meng, Xian-Long
    Wang, Xin-Ying
    Sun, Lei
    Ge, Ning-Ling
    Huang, Xiao-Wu
    Qiu, Shuang-Jian
    Yang, Xin-Rong
    Gao, Qiang
    He, Yi-Feng
    Xu, Yang
    Sun, Jian
    Ren, Zheng-Gang
    Fan, Jia
    Zhou, Jian
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [37] Retrospective analysis of first-line chemotherapy in 132 patients with advanced small-bowel adenocarcinoma.
    Tsushima, T.
    Boku, N.
    Honma, Y.
    Takahashi, H.
    Ueda, S.
    Nishina, T.
    Kawai, H.
    Kato, S.
    Suenaga, M.
    Tamura, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [38] Efficacy and safety analysis of modified biweekly SOX regimen in the first-line treatment of advanced gastric adenocarcinoma or esophagogastric junction adenocarcinoma
    Zhang, S.
    Wang, H.
    Meng, Y.
    Nie, X.
    Huang, C.
    Gao, F.
    Sun, L.
    Liu, Z.
    ANNALS OF ONCOLOGY, 2020, 31 : S911 - S911
  • [39] Camrelizumab combined with apatinib in the treatment of patients with advanced gastric cancer and colorectal cancer: One-arm exploratory clinical trial
    Xiao, L.
    Zhang, Y.
    Lin, Q.
    ANNALS OF ONCOLOGY, 2020, 31 : S429 - S429
  • [40] Camrelizumab combined with apatinib and hepatic artery infusion chemotherapy (HAIC) as conversion therapy for patients with unresectable hepatocellular carcinoma(HCC): A single-arm exploratory clinical study
    Zhao, Lei
    Zhang, Bo
    Shi, Xuetao
    Cui, Kai
    Zhang, Jianxin
    Zhong, Jingtao
    Li, Zhongchao
    Sun, Pengfei
    Zhang, Chengsheng
    Li, Lei
    CANCER RESEARCH, 2024, 84 (06)
12345